| NCT04220099 |
Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia |
https://ClinicalTrials.gov/show/NCT04220099 |
Completed |
Shanghai Mental Health Center |
2020-06-05 |
| NCT03919994 |
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) |
https://ClinicalTrials.gov/show/NCT03919994 |
Recruiting |
Alkermes, Inc. |
2022-10-31 |
| NCT03820362 |
The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique |
https://ClinicalTrials.gov/show/NCT03820362 |
Completed |
University of Barcelona |
2018-11-30 |
| NCT00001486 |
Genetic Study of Schizophrenia |
https://ClinicalTrials.gov/show/NCT00001486 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03355781 |
Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology |
https://ClinicalTrials.gov/show/NCT03355781 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2022-01-31 |
| NCT03253367 |
Phenomics and Genomics of Clozapine Pharmacotherapy |
https://ClinicalTrials.gov/show/NCT03253367 |
Recruiting |
UMC Utrecht |
2021-12-31 |
| NCT03235908 |
Copeptin in Outcome Prediction of an Acute Psychotic Episode |
https://ClinicalTrials.gov/show/NCT03235908 |
Active, not recruiting |
University Hospital, Basel, Switzerland |
2020-07-31 |
| NCT03166098 |
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders |
https://ClinicalTrials.gov/show/NCT03166098 |
Active, not recruiting |
NYU Langone Health |
2020-11-30 |
| NCT03131505 |
INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 |
https://ClinicalTrials.gov/show/NCT03131505 |
Completed |
Norfolk and Suffolk NHS Foundation Trust |
2017-12-01 |
| NCT03130478 |
Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain |
https://ClinicalTrials.gov/show/NCT03130478 |
Completed |
Otsuka Pharmaceutical Europe Ltd |
2018-07-30 |
| NCT03130465 |
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia |
https://ClinicalTrials.gov/show/NCT03130465 |
Recruiting |
Otsuka Pharmaceutical Europe Ltd |
2020-01-31 |
| NCT03075202 |
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia |
https://ClinicalTrials.gov/show/NCT03075202 |
Completed |
Weill Medical College of Cornell University |
2018-12-24 |
| NCT03068806 |
Brain Imaging, Attention, and Auditory Processing in Schizophrenia |
https://ClinicalTrials.gov/show/NCT03068806 |
Completed |
San Francisco Veterans Affairs Medical Center |
2018-05-11 |
| NCT03068793 |
Reward Processing in Mental Illness |
https://ClinicalTrials.gov/show/NCT03068793 |
Completed |
San Francisco Veterans Affairs Medical Center |
2019-06-30 |
| NCT03040505 |
Future Mental Projections in Schizophrenia |
https://ClinicalTrials.gov/show/NCT03040505 |
Recruiting |
University Hospital, Strasbourg, France |
2020-04-30 |
| NCT03005769 |
Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy |
https://ClinicalTrials.gov/show/NCT03005769 |
Completed |
Otsuka Pharmaceutical Europe Ltd |
2017-07-31 |
| NCT02930083 |
Validating Three Common Occupational Therapy Assessments in Participants With Schizophrenia |
https://ClinicalTrials.gov/show/NCT02930083 |
Completed |
Taipei City Hospital |
2014-12-31 |
| NCT02921243 |
Schizophrenia and the Gut Microbiome |
https://ClinicalTrials.gov/show/NCT02921243 |
Completed |
University of Maryland, Baltimore |
2019-06-18 |
| NCT02916303 |
Cost-effectiveness of Interventions in First-episode Psychosis |
https://ClinicalTrials.gov/show/NCT02916303 |
Enrolling by invitation |
Fundación Marques de Valdecilla |
2017-07-31 |
| NCT02897167 |
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients |
https://ClinicalTrials.gov/show/NCT02897167 |
Completed |
Fundación Marques de Valdecilla |
2018-12-31 |
| NCT02874560 |
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia |
https://ClinicalTrials.gov/show/NCT02874560 |
Completed |
Janssen-Cilag Ltd. |
2017-06-30 |
| NCT02874482 |
Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT02874482 |
Recruiting |
University Hospital, Lille |
2020-08-31 |
| NCT02868879 |
Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and Cataphasia |
https://ClinicalTrials.gov/show/NCT02868879 |
Completed |
University Hospital, Strasbourg, France |
2019-09-30 |
| NCT02775864 |
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia |
https://ClinicalTrials.gov/show/NCT02775864 |
Completed |
New York State Psychiatric Institute |
2018-04-30 |
| NCT02773108 |
Somatic Comorbidities in Psychiatric Patients |
https://ClinicalTrials.gov/show/NCT02773108 |
Completed |
Sveti Ivan Psychiatric Hospital |
2016-06-30 |
| NCT02756065 |
Connectomics in Psychiatric Classification of Bipolar Disorder and Schizophrenia |
https://ClinicalTrials.gov/show/NCT02756065 |
Recruiting |
Washington University Early Recognition Center |
2019-06-30 |
| NCT02714894 |
Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study |
https://ClinicalTrials.gov/show/NCT02714894 |
Recruiting |
Centre for Addiction and Mental Health |
2021-03-31 |
| NCT02712463 |
A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics |
https://ClinicalTrials.gov/show/NCT02712463 |
Completed |
Janssen-Cilag Ltd. |
2016-04-30 |
| NCT02681822 |
Multi-center Imaging Genetics Studies in China |
https://ClinicalTrials.gov/show/NCT02681822 |
Recruiting |
Tianjin Medical University General Hospital |
2019-12-31 |
| NCT02640911 |
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT02640911 |
Recruiting |
Shanghai Mental Health Center |
2021-05-31 |
| NCT02600741 |
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) |
https://ClinicalTrials.gov/show/NCT02600741 |
Completed |
Janssen Scientific Affairs, LLC |
2018-07-05 |
| NCT00001247 |
Inpatient Evaluation of Adults With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00001247 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02582736 |
Antipsychotics and Risk of Hyperglycemic Emergencies |
https://ClinicalTrials.gov/show/NCT02582736 |
Completed |
Canadian Network for Observational Drug Effect Studies, CNODES |
2012-12-31 |
| NCT02575209 |
Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects |
https://ClinicalTrials.gov/show/NCT02575209 |
Completed |
Corporacion Parc Tauli |
2016-07-31 |
| NCT00942981 |
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography |
https://ClinicalTrials.gov/show/NCT00942981 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00024622 |
PET Scanning in Parkinson s Disease |
https://ClinicalTrials.gov/show/NCT00024622 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001246 |
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00001246 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02034253 |
Glutamate, Brain Connectivity and Duration of Untreated Psychosis |
https://ClinicalTrials.gov/show/NCT02034253 |
Completed |
University of Alabama at Birmingham |
2018-11-30 |
| NCT02532842 |
Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate |
https://ClinicalTrials.gov/show/NCT02532842 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2015-09-30 |
| NCT02505022 |
Role Functioning Changes NOS |
https://ClinicalTrials.gov/show/NCT02505022 |
Recruiting |
Northwestern University |
2021-01-31 |
| NCT02476877 |
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse |
https://ClinicalTrials.gov/show/NCT02476877 |
Completed |
Advanced Clinical Laboratory Solutions, Inc. |
2016-01-31 |
| NCT02453763 |
In Vivo Imaging of Therapeutic Electric Current Flow |
https://ClinicalTrials.gov/show/NCT02453763 |
Completed |
University of Florida |
2017-07-06 |
| NCT02439099 |
Retinoic Acid Homeostasis in Neuropsychiatric Diseases |
https://ClinicalTrials.gov/show/NCT02439099 |
Recruiting |
Charite University, Berlin, Germany |
2019-12-31 |
| NCT03386851 |
Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder |
https://ClinicalTrials.gov/show/NCT03386851 |
Recruiting |
Korea Otsuka Pharmaceutical Co., Ltd. |
2021-12-22 |
| NCT02409823 |
Clinical Registry of Patients Under Treatment With Atypical Antipsychotics |
https://ClinicalTrials.gov/show/NCT02409823 |
Completed |
Pontifical Catholic University of Argentina |
2015-08-31 |
| NCT02388607 |
Sustained Attention Abilities in Schizophrenia |
https://ClinicalTrials.gov/show/NCT02388607 |
Recruiting |
University Hospital, Strasbourg, France |
2021-03-31 |
| NCT02321943 |
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study |
https://ClinicalTrials.gov/show/NCT02321943 |
Completed |
Sykehuset Innlandet HF |
2016-12-31 |
| NCT02281162 |
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain |
https://ClinicalTrials.gov/show/NCT02281162 |
Completed |
Creighton University |
2015-09-30 |
| NCT02246283 |
Schizophrenia for “Life” - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia |
https://ClinicalTrials.gov/show/NCT02246283 |
Completed |
University of Southern Denmark |
2015-09-30 |
| NCT02248987 |
Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia |
https://ClinicalTrials.gov/show/NCT02248987 |
Completed |
Seoul National University Hospital |
2016-05-31 |
| NCT02205437 |
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia |
https://ClinicalTrials.gov/show/NCT02205437 |
Recruiting |
Fundación Marques de Valdecilla |
2020-12-31 |
| NCT02187835 |
Decreased EEG Complexity in Schizophrenia |
https://ClinicalTrials.gov/show/NCT02187835 |
Completed |
Uskudar University |
2014-01-31 |
| NCT02166918 |
Factors Influencing Social Functioning of People With Schizophrenia |
https://ClinicalTrials.gov/show/NCT02166918 |
Completed |
University of Campania “Luigi Vanvitelli” |
2014-07-31 |
| NCT02118571 |
Schizophrenia Cognition Scale Development |
https://ClinicalTrials.gov/show/NCT02118571 |
Completed |
HealthCore-NERI |
2016-07-31 |
| NCT01315509 |
Dental Status of Patients With Severe Mental Illness |
https://ClinicalTrials.gov/show/NCT01315509 |
Completed |
Hadassah Medical Organization |
2012-09-30 |
| NCT01309373 |
An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01309373 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT01298349 |
Perception Processing in Schizophrenia Patients and Normal Population |
https://ClinicalTrials.gov/show/NCT01298349 |
Completed |
HaEmek Medical Center, Israel |
2016-12-31 |
| NCT01269710 |
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study |
https://ClinicalTrials.gov/show/NCT01269710 |
Completed |
University of North Carolina, Chapel Hill |
2011-03-31 |
| NCT02050854 |
Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia |
https://ClinicalTrials.gov/show/NCT02050854 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2014-01-31 |
| NCT02009826 |
Psychosis-Associated Neuroinflammation in Schizophrenia |
https://ClinicalTrials.gov/show/NCT02009826 |
Completed |
Universiteit Antwerpen |
2017-02-28 |
| NCT02006862 |
eVAluatIon of OLanzapine TreatmEnT |
https://ClinicalTrials.gov/show/NCT02006862 |
Completed |
Elpen Pharmaceutical Co. Inc. |
2014-12-31 |
| NCT01998516 |
Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder |
https://ClinicalTrials.gov/show/NCT01998516 |
Completed |
Medical University Innsbruck |
2016-12-31 |
| NCT01959659 |
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness |
https://ClinicalTrials.gov/show/NCT01959659 |
Completed |
Hoffmann-La Roche |
2014-04-30 |
| NCT01943175 |
Stem Cell Research on Subjects at Genetic High Risk for Schizophrenia |
https://ClinicalTrials.gov/show/NCT01943175 |
Completed |
Seoul National University Hospital |
2015-11-30 |
| NCT01926912 |
A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting |
https://ClinicalTrials.gov/show/NCT01926912 |
Completed |
Janssen-Cilag International NV |
2014-08-31 |
| NCT01926340 |
Early Medication Discontinuation and Long-term Clinical Outcome in FEP |
https://ClinicalTrials.gov/show/NCT01926340 |
Completed |
The University of Hong Kong |
2014-12-31 |
| NCT01886417 |
Auditory Verbal Hallucinations in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01886417 |
Completed |
University Hospital, Grenoble |
2015-03-31 |
| NCT01846065 |
Tobacco Craving and Triggers in Persons With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01846065 |
Completed |
University of Maryland, Baltimore |
2016-06-30 |
| NCT01819818 |
A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients |
https://ClinicalTrials.gov/show/NCT01819818 |
Completed |
Janssen Korea, Ltd., Korea |
2019-11-29 |
| NCT01795326 |
Physician Survey on Monitoring of Patients Treated With Quetiapine |
https://ClinicalTrials.gov/show/NCT01795326 |
Completed |
AstraZeneca |
2013-09-30 |
| NCT01793324 |
EMR Data to Assess Monitoring of Patients Treated With Quetiapine |
https://ClinicalTrials.gov/show/NCT01793324 |
Completed |
AstraZeneca |
2013-06-30 |
| NCT01786369 |
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics. |
https://ClinicalTrials.gov/show/NCT01786369 |
Completed |
Northwell Health |
2015-04-30 |
| NCT01754532 |
Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels |
https://ClinicalTrials.gov/show/NCT01754532 |
Completed |
Shalvata Mental Health Center |
2015-06-30 |
| NCT01746134 |
The Management of Schizophrenia in Clinical Practice (MOSAIC) |
https://ClinicalTrials.gov/show/NCT01746134 |
Completed |
Genentech, Inc. |
2014-05-31 |
| NCT01730781 |
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning |
https://ClinicalTrials.gov/show/NCT01730781 |
Recruiting |
Yale University |
2020-12-31 |
| NCT01689389 |
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study |
https://ClinicalTrials.gov/show/NCT01689389 |
Completed |
AstraZeneca |
2014-12-31 |
| NCT01686815 |
Cross-Sectional Iloperidone IVGTT |
https://ClinicalTrials.gov/show/NCT01686815 |
Completed |
Massachusetts General Hospital |
2016-05-31 |
| NCT01660880 |
Validation of Receptor Occupancy Simulation |
https://ClinicalTrials.gov/show/NCT01660880 |
Completed |
Seoul National University Hospital |
2013-12-31 |
| NCT01634542 |
An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia |
https://ClinicalTrials.gov/show/NCT01634542 |
Completed |
Hoffmann-La Roche |
2014-12-31 |
| NCT01629355 |
Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder |
https://ClinicalTrials.gov/show/NCT01629355 |
Completed |
University Hospital of North Norway |
2015-05-31 |
| NCT01602263 |
Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing |
https://ClinicalTrials.gov/show/NCT01602263 |
Active, not recruiting |
Johns Hopkins University |
2025-01-31 |
| NCT01590784 |
Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS) |
https://ClinicalTrials.gov/show/NCT01590784 |
Completed |
Chiang Mai University |
2014-06-30 |
| NCT01587521 |
Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01587521 |
Completed |
Chiang Mai University |
2016-06-30 |
| NCT01575912 |
Past Pain Experience and Perception of Experimental Pain |
https://ClinicalTrials.gov/show/NCT01575912 |
Completed |
Centre Hospitalier Esquirol |
2014-01-31 |
| NCT01558570 |
Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin |
https://ClinicalTrials.gov/show/NCT01558570 |
Completed |
University of Maryland, Baltimore |
2012-02-29 |
| NCT01544608 |
Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia |
https://ClinicalTrials.gov/show/NCT01544608 |
Completed |
AstraZeneca |
2012-12-31 |
| NCT01495741 |
Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307) |
https://ClinicalTrials.gov/show/NCT01495741 |
Completed |
Merck Sharp & Dohme Corp. |
2017-12-18 |
| NCT01491412 |
Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia |
https://ClinicalTrials.gov/show/NCT01491412 |
Completed |
AstraZeneca |
NA |
| NCT01479413 |
Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs |
https://ClinicalTrials.gov/show/NCT01479413 |
Completed |
Chang Gung Memorial Hospital |
2012-07-31 |
| NCT01479400 |
Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study |
https://ClinicalTrials.gov/show/NCT01479400 |
Completed |
Central South University |
2010-12-31 |
| NCT01447082 |
General Practice Research Database Seroquel XR Safety Study |
https://ClinicalTrials.gov/show/NCT01447082 |
Completed |
AstraZeneca |
2012-12-31 |
| NCT01431326 |
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care |
https://ClinicalTrials.gov/show/NCT01431326 |
Completed |
Duke University |
2019-11-30 |
| NCT01425684 |
Brain Circuits in Schizophrenia and Smoking |
https://ClinicalTrials.gov/show/NCT01425684 |
Recruiting |
University of Maryland, Baltimore |
2020-01-31 |
| NCT01425671 |
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States |
https://ClinicalTrials.gov/show/NCT01425671 |
Active, not recruiting |
University of Maryland, Baltimore |
2020-01-31 |
| NCT01409109 |
Database Registry for Neural Network Biomarkers in Psychosis |
https://ClinicalTrials.gov/show/NCT01409109 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2023-05-31 |
| NCT01399437 |
Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01399437 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01394601 |
A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia |
https://ClinicalTrials.gov/show/NCT01394601 |
Completed |
AstraZeneca |
2011-12-31 |
| NCT01392885 |
Brain Health and Exercise in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01392885 |
Enrolling by invitation |
BC Mental Health and Addictions Research Institute |
2016-06-30 |
| NCT01392482 |
IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder |
https://ClinicalTrials.gov/show/NCT01392482 |
Completed |
AstraZeneca |
2012-09-30 |
| NCT01384604 |
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders |
https://ClinicalTrials.gov/show/NCT01384604 |
Completed |
University of Texas Southwestern Medical Center |
2013-05-31 |
| NCT01383915 |
Clinical Risk State for Bipolar Disorder in Adolescents |
https://ClinicalTrials.gov/show/NCT01383915 |
Recruiting |
Northwell Health |
2022-12-31 |
| NCT01378403 |
Evaluation of Dorsal Visual Stream in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01378403 |
Completed |
Sheba Medical Center |
2010-07-31 |
| NCT01377896 |
The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours |
https://ClinicalTrials.gov/show/NCT01377896 |
Completed |
AstraZeneca |
2010-10-31 |
| NCT01376492 |
FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain |
https://ClinicalTrials.gov/show/NCT01376492 |
Completed |
Janssen-Cilag, S.A. |
2011-07-31 |
| NCT01369966 |
Brain Circuits in Schizophrenia and Smoking |
https://ClinicalTrials.gov/show/NCT01369966 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01362426 |
Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL) |
https://ClinicalTrials.gov/show/NCT01362426 |
Completed |
Janssen-Cilag Pty Ltd |
2013-05-31 |
| NCT01342120 |
PHARMO Institute Seroquel Safety Study |
https://ClinicalTrials.gov/show/NCT01342120 |
Completed |
AstraZeneca |
2010-11-30 |
| NCT04335916 |
Survey on Pre-ECT Evaluation and ECT Application |
https://ClinicalTrials.gov/show/NCT04335916 |
Recruiting |
KliniÄki BolniÄki Centar Zagreb |
2020-09-01 |
| NCT04294719 |
A Study of Cognitive Adaptation Training in Inpatient Forensic Environments |
https://ClinicalTrials.gov/show/NCT04294719 |
Recruiting |
Centre for Addiction and Mental Health |
2020-06-30 |
| NCT04280367 |
Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age |
https://ClinicalTrials.gov/show/NCT04280367 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-02-28 |
| NCT04230590 |
Health Outcomes Via Positive Engagement in Schizophrenia |
https://ClinicalTrials.gov/show/NCT04230590 |
Recruiting |
Institute of Mental Health, Singapore |
2022-04-30 |
| NCT04191200 |
Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital |
https://ClinicalTrials.gov/show/NCT04191200 |
Completed |
Centre Hospitalier Charles Perrens, Bordeaux |
2019-12-31 |
| NCT04064476 |
The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk |
https://ClinicalTrials.gov/show/NCT04064476 |
Enrolling by invitation |
Huazhong University of Science and Technology |
2021-08-15 |
| NCT04051775 |
Non-Pharmacological Treatment of Psychosis |
https://ClinicalTrials.gov/show/NCT04051775 |
Recruiting |
Haukeland University Hospital |
2022-06-30 |
| NCT04025502 |
Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects |
https://ClinicalTrials.gov/show/NCT04025502 |
Recruiting |
ERP Biomarker Qualification Consortium |
2020-02-29 |
| NCT04024371 |
Validating Reward-related Biomarkers (RTOC) |
https://ClinicalTrials.gov/show/NCT04024371 |
Recruiting |
Maastricht University |
2020-08-01 |
| NCT04002258 |
Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment |
https://ClinicalTrials.gov/show/NCT04002258 |
Active, not recruiting |
Shanghai Mental Health Center |
2020-11-30 |
| NCT03996122 |
Research of Anatomo-functional Biomarkers in Schizophrenia |
https://ClinicalTrials.gov/show/NCT03996122 |
Recruiting |
University Hospital, Caen |
2021-04-04 |
| NCT03995121 |
SV2 PET Imaging With [11C]APP311 |
https://ClinicalTrials.gov/show/NCT03995121 |
Active, not recruiting |
Yale University |
2023-12-31 |
| NCT03965598 |
Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group |
https://ClinicalTrials.gov/show/NCT03965598 |
Recruiting |
Second Xiangya Hospital of Central South University |
2021-12-31 |
| NCT03919760 |
Early Psychosis Intervention - Spreading Evidence-based Treatment |
https://ClinicalTrials.gov/show/NCT03919760 |
Recruiting |
Centre for Addiction and Mental Health |
2023-05-31 |
| NCT03809325 |
A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly |
https://ClinicalTrials.gov/show/NCT03809325 |
Completed |
Janssen-Cilag International NV |
2019-07-12 |
| NCT03788811 |
ERG Components in Schizophrenia and Bipolar Disorder Type I |
https://ClinicalTrials.gov/show/NCT03788811 |
Recruiting |
diaMentis Inc. |
2020-12-31 |
| NCT03702933 |
D-serine in Schizophrenia |
https://ClinicalTrials.gov/show/NCT03702933 |
Recruiting |
Herzog Hospital |
2021-09-01 |
| NCT03699501 |
Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia |
https://ClinicalTrials.gov/show/NCT03699501 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2020-11-30 |
| NCT03675750 |
Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism |
https://ClinicalTrials.gov/show/NCT03675750 |
Recruiting |
Shanghai Mental Health Center |
2020-04-30 |
| NCT03693794 |
A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics |
https://ClinicalTrials.gov/show/NCT03693794 |
Recruiting |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2020-07-01 |
| NCT03666715 |
A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal |
https://ClinicalTrials.gov/show/NCT03666715 |
Recruiting |
Janssen-Cilag Farmaceutica Ltda. |
2020-10-30 |
| NCT03629951 |
A Study for Schizophrenia Relapse Prediction |
https://ClinicalTrials.gov/show/NCT03629951 |
Active, not recruiting |
Janssen Research & Development, LLC |
2021-11-14 |
| NCT03558529 |
Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse |
https://ClinicalTrials.gov/show/NCT03558529 |
Completed |
Manchester Academic Health Science Centre |
2018-04-01 |
| NCT03528278 |
Using Motivational Techniques to Increase Levels of Physical Activity in Long Term Psychiatric Inpatient Wards |
https://ClinicalTrials.gov/show/NCT03528278 |
Completed |
Oslo University Hospital |
2015-03-10 |
| NCT03525054 |
Semantic and Syntactic Computerized Analysis of Free Speech |
https://ClinicalTrials.gov/show/NCT03525054 |
Recruiting |
University Hospital, Brest |
2022-05-18 |
| NCT03523741 |
Therapeutic Drug Monitoring for Individualized Clozapine Therapy |
https://ClinicalTrials.gov/show/NCT03523741 |
Recruiting |
Seoul National University Hospital |
2020-11-30 |
| NCT03513549 |
Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder |
https://ClinicalTrials.gov/show/NCT03513549 |
Recruiting |
Galen Limited |
2019-10-31 |
| NCT03485339 |
Substance Misuse To Psychosis for Ketamine (SToP-K) |
https://ClinicalTrials.gov/show/NCT03485339 |
Active, not recruiting |
The University of Hong Kong |
2020-06-05 |
| NCT03481465 |
Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis |
https://ClinicalTrials.gov/show/NCT03481465 |
Enrolling by invitation |
Fundación Marques de Valdecilla |
2019-12-31 |
| NCT03476473 |
Early Detection of Respiratory Disorders in Psychosis |
https://ClinicalTrials.gov/show/NCT03476473 |
Enrolling by invitation |
Fundación Marques de Valdecilla |
2018-03-26 |
| NCT03471013 |
Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT03471013 |
Recruiting |
University Hospital, Clermont-Ferrand |
2019-03-02 |
| NCT03449407 |
Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psychosis |
https://ClinicalTrials.gov/show/NCT03449407 |
Completed |
Chinese University of Hong Kong |
2019-06-30 |
| NCT03414151 |
Gut Microbiome in AP Naive |
https://ClinicalTrials.gov/show/NCT03414151 |
Recruiting |
Centre for Addiction and Mental Health |
2022-03-31 |
| NCT01245348 |
Relative Effectiveness of Schizophrenia Therapy Study |
https://ClinicalTrials.gov/show/NCT01245348 |
Completed |
Medco Health Solutions, Inc. |
2012-12-31 |
| NCT01243034 |
Waist Circumference Measurements in Schizophrenic Patients |
https://ClinicalTrials.gov/show/NCT01243034 |
Completed |
Changhua Christian Hospital |
2011-07-31 |
| NCT01222793 |
Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01222793 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01214135 |
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01214135 |
Completed |
AstraZeneca |
2010-12-31 |
| NCT01212575 |
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01212575 |
Completed |
AstraZeneca |
2011-02-28 |
| NCT01212081 |
Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality |
https://ClinicalTrials.gov/show/NCT01212081 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01202617 |
Seroquel XR in the Long Term Treatment of Schizophrenia |
https://ClinicalTrials.gov/show/NCT01202617 |
Completed |
AstraZeneca |
2011-10-31 |
| NCT01196858 |
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland |
https://ClinicalTrials.gov/show/NCT01196858 |
Completed |
University Hospital of North Norway |
2013-09-30 |
| NCT01191827 |
fMRI Cholinergic Mechanisms in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01191827 |
Completed |
VA Office of Research and Development |
2011-12-31 |
| NCT01181960 |
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations |
https://ClinicalTrials.gov/show/NCT01181960 |
Completed |
Janssen Scientific Affairs, LLC |
2013-11-30 |
| NCT01170689 |
The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan |
https://ClinicalTrials.gov/show/NCT01170689 |
Completed |
TsaoTun Psychiatric Center, Department of Health, Taiwan |
2010-03-31 |
| NCT01160679 |
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01160679 |
Completed |
AstraZeneca |
2011-08-31 |
| NCT01150734 |
Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation) |
https://ClinicalTrials.gov/show/NCT01150734 |
Completed |
Ludwig-Maximilians - University of Munich |
2010-12-31 |
| NCT01149551 |
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness |
https://ClinicalTrials.gov/show/NCT01149551 |
Completed |
VA Office of Research and Development |
2014-06-30 |
| NCT01138618 |
Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ) |
https://ClinicalTrials.gov/show/NCT01138618 |
Completed |
University of Aarhus |
2010-12-31 |
| NCT01092598 |
Factors Association With Poor Physical Function in Older Adults With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01092598 |
Completed |
University of California, San Francisco |
2012-06-30 |
| NCT01088386 |
Zyprexa® Relprevv™ Patient Care Program |
https://ClinicalTrials.gov/show/NCT01088386 |
Enrolling by invitation |
Eli Lilly and Company |
2021-05-31 |
| NCT01053429 |
A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule |
https://ClinicalTrials.gov/show/NCT01053429 |
Completed |
Pfizer |
2010-02-28 |
| NCT01046526 |
fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia |
https://ClinicalTrials.gov/show/NCT01046526 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01044914 |
Genes, Intermediate Phenotypes and Response to Quetiapine RX |
https://ClinicalTrials.gov/show/NCT01044914 |
Completed |
University of Bari |
2010-10-31 |
| NCT01043250 |
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients |
https://ClinicalTrials.gov/show/NCT01043250 |
Completed |
Samsung Medical Center |
2010-04-30 |
| NCT01037075 |
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence |
https://ClinicalTrials.gov/show/NCT01037075 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01034085 |
Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01034085 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01036568 |
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01036568 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01031563 |
Risk Perception in Drug-Dependent Adults With and Without Schizophrenia |
https://ClinicalTrials.gov/show/NCT01031563 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01035996 |
Dopamine Function and Reward Processing In Schizophrenia |
https://ClinicalTrials.gov/show/NCT01035996 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01031433 |
Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality |
https://ClinicalTrials.gov/show/NCT01031433 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01028196 |
Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression |
https://ClinicalTrials.gov/show/NCT01028196 |
Completed |
AstraZeneca |
2010-11-30 |
| NCT01026285 |
InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics |
https://ClinicalTrials.gov/show/NCT01026285 |
Completed |
Janssen-Cilag International NV |
2012-03-31 |
| NCT01010620 |
Screening Protocol for Research Participants |
https://ClinicalTrials.gov/show/NCT01010620 |
Completed |
University of Maryland, Baltimore |
2019-06-01 |
| NCT01001481 |
Schizophrenia Treatment Adherence Investigation (STAI) |
https://ClinicalTrials.gov/show/NCT01001481 |
Completed |
Janssen-Cilag Pty Ltd |
2009-09-30 |
| NCT00999895 |
A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients |
https://ClinicalTrials.gov/show/NCT00999895 |
Completed |
AstraZeneca |
2010-09-30 |
| NCT00990626 |
Seroquel XR in Schizophrenia Relapse Prevention |
https://ClinicalTrials.gov/show/NCT00990626 |
Completed |
AstraZeneca |
2010-07-31 |
| NCT00984373 |
Epidemiology of Schizophrenia in Bulgaria |
https://ClinicalTrials.gov/show/NCT00984373 |
Completed |
AstraZeneca |
2009-11-30 |
| NCT00981123 |
Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia |
https://ClinicalTrials.gov/show/NCT00981123 |
Completed |
AstraZeneca |
2010-04-30 |
| NCT00957294 |
Metabolic Syndrome in Patients With First-episode Schizophrenia |
https://ClinicalTrials.gov/show/NCT00957294 |
Completed |
University of Aarhus |
2013-04-30 |
| NCT00951418 |
Serum Clozapine and Cognition |
https://ClinicalTrials.gov/show/NCT00951418 |
Completed |
University of Aarhus |
2010-03-31 |
| NCT00952757 |
Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine |
https://ClinicalTrials.gov/show/NCT00952757 |
Completed |
Investigaciones Médicas Montejo S.L. |
2008-08-31 |
| NCT00937755 |
The Study of Atypical Antipsychotics-induced Metabolic Disturbances |
https://ClinicalTrials.gov/show/NCT00937755 |
Completed |
Taipei Medical University Hospital |
2009-03-31 |
| NCT00937716 |
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies |
https://ClinicalTrials.gov/show/NCT00937716 |
Active, not recruiting |
University of Alabama at Birmingham |
2020-12-31 |
| NCT00934726 |
Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00934726 |
Completed |
AstraZeneca |
2010-10-31 |
| NCT00921362 |
Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme |
https://ClinicalTrials.gov/show/NCT00921362 |
Completed |
AstraZeneca |
NA |
| NCT00922090 |
A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended |
https://ClinicalTrials.gov/show/NCT00922090 |
Completed |
AstraZeneca |
2010-01-31 |
| NCT00877552 |
Prospective Studies of the Pathogenesis of Schizophrenia |
https://ClinicalTrials.gov/show/NCT00877552 |
Completed |
University of North Carolina, Chapel Hill |
2019-12-31 |
| NCT00873249 |
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00873249 |
Completed |
AstraZeneca |
2010-03-31 |
| NCT00857064 |
Subjective Well Being of Schizophrenic Patients in Greece |
https://ClinicalTrials.gov/show/NCT00857064 |
Completed |
AstraZeneca |
2009-10-31 |
| NCT00824031 |
Study of Mental Care in Spain |
https://ClinicalTrials.gov/show/NCT00824031 |
Completed |
AstraZeneca |
NA |
| NCT01534936 |
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary |
https://ClinicalTrials.gov/show/NCT01534936 |
Completed |
AstraZeneca |
2012-12-31 |
| NCT00838123 |
Cognitive Functioning Related to Job Tenure Among Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00838123 |
Completed |
Far Eastern Memorial Hospital |
NA |
| NCT00814996 |
Social Functioning in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00814996 |
Completed |
Far Eastern Memorial Hospital |
2008-08-31 |
| NCT00809731 |
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment |
https://ClinicalTrials.gov/show/NCT00809731 |
Completed |
AstraZeneca |
2010-09-30 |
| NCT01698216 |
Switching From Consta® to Sustenna® in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01698216 |
Completed |
Seoul National University Hospital |
2015-05-31 |
| NCT03076346 |
Neural Biomarkers of Clozapine Response |
https://ClinicalTrials.gov/show/NCT03076346 |
Recruiting |
University of Pittsburgh |
2020-06-30 |
| NCT02882204 |
Tracking Outcomes in Psychosis |
https://ClinicalTrials.gov/show/NCT02882204 |
Recruiting |
Lawson Health Research Institute |
2022-12-31 |
| NCT00782899 |
Four Dimensions in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00782899 |
Completed |
AstraZeneca |
2009-09-30 |
| NCT00774085 |
An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone |
https://ClinicalTrials.gov/show/NCT00774085 |
Completed |
Janssen Cilag N.V./S.A. |
2007-12-31 |
| NCT00758251 |
Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment |
https://ClinicalTrials.gov/show/NCT00758251 |
Completed |
AstraZeneca |
2009-03-31 |
| NCT00750087 |
Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR |
https://ClinicalTrials.gov/show/NCT00750087 |
Completed |
AstraZeneca |
2009-09-30 |
| NCT00749970 |
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00749970 |
Completed |
AstraZeneca |
2009-01-31 |
| NCT00696813 |
Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics |
https://ClinicalTrials.gov/show/NCT00696813 |
Completed |
Janssen-Cilag International NV |
2011-01-31 |
| NCT00690365 |
Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00690365 |
Completed |
AstraZeneca |
2008-04-30 |
| NCT00692133 |
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment |
https://ClinicalTrials.gov/show/NCT00692133 |
Completed |
AstraZeneca |
2008-08-31 |
| NCT00689325 |
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics |
https://ClinicalTrials.gov/show/NCT00689325 |
Completed |
AstraZeneca |
2010-01-31 |
| NCT00686101 |
Knowledge and Perception of Smoking Risks/Consequences |
https://ClinicalTrials.gov/show/NCT00686101 |
Completed |
University of Maryland, Baltimore |
2009-06-30 |
| NCT00683891 |
FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey |
https://ClinicalTrials.gov/show/NCT00683891 |
Completed |
Azur Pharma, Inc |
NA |
| NCT00697658 |
INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00697658 |
Completed |
Janssen-Cilag B.V. |
2009-11-30 |
| NCT00666432 |
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes |
https://ClinicalTrials.gov/show/NCT00666432 |
Active, not recruiting |
University of Maryland, Baltimore |
2012-09-30 |
| NCT00666146 |
Familial Schizophrenia and Spectrum Personality Disorders |
https://ClinicalTrials.gov/show/NCT00666146 |
Active, not recruiting |
University of Maryland, Baltimore |
2010-07-31 |
| NCT00644852 |
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone |
https://ClinicalTrials.gov/show/NCT00644852 |
Completed |
Johnson & Johnson Taiwan Ltd |
2007-09-30 |
| NCT00597168 |
Quality of Life in Schizophrenic Patients |
https://ClinicalTrials.gov/show/NCT00597168 |
Completed |
AstraZeneca |
2009-10-31 |
| NCT01259232 |
The Imaging Genetic Study of Schizophrenia and Family |
https://ClinicalTrials.gov/show/NCT01259232 |
Recruiting |
Kunming Medical University |
2022-12-31 |
| NCT00584519 |
Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight |
https://ClinicalTrials.gov/show/NCT00584519 |
Completed |
Pfizer |
2009-06-30 |
| NCT00585273 |
Antipsychotics and Blood Vessel Function |
https://ClinicalTrials.gov/show/NCT00585273 |
Completed |
University of Iowa |
2014-11-30 |
| NCT00581932 |
Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine |
https://ClinicalTrials.gov/show/NCT00581932 |
Completed |
University of Iowa |
2015-12-31 |
| NCT00579670 |
Treatment of Schizophrenic Patients With Ziprasidone |
https://ClinicalTrials.gov/show/NCT00579670 |
Completed |
Pfizer |
2009-04-30 |
| NCT00573300 |
Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study |
https://ClinicalTrials.gov/show/NCT00573300 |
Completed |
North Suffolk Mental Health Association |
2009-05-31 |
| NCT00562926 |
Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese |
https://ClinicalTrials.gov/show/NCT00562926 |
Completed |
Hospital Authority, Hong Kong |
NA |
| NCT00560677 |
Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study) |
https://ClinicalTrials.gov/show/NCT00560677 |
Active, not recruiting |
Durham VA Medical Center |
2021-12-31 |
| NCT00543088 |
Effectiveness of Anti-Psychotic in GPs Setting |
https://ClinicalTrials.gov/show/NCT00543088 |
Completed |
AstraZeneca |
NA |
| NCT00540267 |
Bone Density in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00540267 |
Completed |
Inje University |
2008-11-30 |
| NCT00538122 |
Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment |
https://ClinicalTrials.gov/show/NCT00538122 |
Completed |
Vanderbilt University |
2008-07-31 |
| NCT00538629 |
Noninterventional Study in Bipolar Disorder and Schizophrenia With Zeldox |
https://ClinicalTrials.gov/show/NCT00538629 |
Completed |
Pfizer |
2008-04-30 |
| NCT00536783 |
Schizophrenia Sensory Gating Deficit With Quetiapine |
https://ClinicalTrials.gov/show/NCT00536783 |
Completed |
New Mexico VA Healthcare System |
NA |
| NCT00534222 |
Unraveling the Relation of Patient’s Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect |
https://ClinicalTrials.gov/show/NCT00534222 |
Completed |
AstraZeneca |
NA |
| NCT00533260 |
A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) |
https://ClinicalTrials.gov/show/NCT00533260 |
Completed |
AstraZeneca |
2008-04-30 |
| NCT00528359 |
β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS |
https://ClinicalTrials.gov/show/NCT00528359 |
Completed |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
NA |
| NCT00524979 |
Digital Voice Analysis in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00524979 |
Completed |
BeerYaakov Mental Health Center |
NA |
| NCT00523783 |
Seroquel Long-Term NIS for Schizophrenia Patients |
https://ClinicalTrials.gov/show/NCT00523783 |
Completed |
AstraZeneca |
2007-11-30 |
| NCT00510211 |
An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. |
https://ClinicalTrials.gov/show/NCT00510211 |
Completed |
Eli Lilly and Company |
NA |
| NCT00501163 |
Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients |
https://ClinicalTrials.gov/show/NCT00501163 |
Completed |
Washington University School of Medicine |
2012-05-31 |
| NCT00501007 |
Predictors of Treatment Outcome for Smokers With and Without Schizophrenia |
https://ClinicalTrials.gov/show/NCT00501007 |
Completed |
Rutgers, The State University of New Jersey |
2012-12-31 |
| NCT00458367 |
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT00458367 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
NA |
| NCT00448630 |
An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics |
https://ClinicalTrials.gov/show/NCT00448630 |
Completed |
Pfizer |
2008-07-31 |
| NCT00423033 |
Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients |
https://ClinicalTrials.gov/show/NCT00423033 |
Completed |
Far Eastern Memorial Hospital |
2007-09-30 |
| NCT00419016 |
Association Between Schizophrenia and Cancer |
https://ClinicalTrials.gov/show/NCT00419016 |
Completed |
Sheba Medical Center |
NA |
| NCT00399334 |
PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders |
https://ClinicalTrials.gov/show/NCT00399334 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT00392743 |
A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients |
https://ClinicalTrials.gov/show/NCT00392743 |
Completed |
GlaxoSmithKline |
2007-05-31 |
| NCT00382915 |
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder |
https://ClinicalTrials.gov/show/NCT00382915 |
Completed |
Rutgers, The State University of New Jersey |
2010-09-30 |
| NCT00376233 |
Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00376233 |
Completed |
University of Jena |
NA |
| NCT00377117 |
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II |
https://ClinicalTrials.gov/show/NCT00377117 |
Completed |
Lawson Health Research Institute |
NA |
| NCT00358852 |
Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00358852 |
Completed |
Janssen-Cilag, S.A. |
2008-09-30 |
| NCT00350935 |
Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study |
https://ClinicalTrials.gov/show/NCT00350935 |
Completed |
University Hospital, Strasbourg, France |
NA |
| NCT00350805 |
Measuring Time Windows in Patients With Schizophrenia and Healthy Controls |
https://ClinicalTrials.gov/show/NCT00350805 |
Completed |
University Hospital, Strasbourg, France |
2012-04-30 |
| NCT00328952 |
Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00328952 |
Completed |
Seoul National University Hospital |
2008-08-31 |
| NCT00319904 |
The Partners Genetics Collaborative Study of Schizophrenia |
https://ClinicalTrials.gov/show/NCT00319904 |
Completed |
Massachusetts General Hospital |
2017-10-31 |
| NCT00312598 |
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine |
https://ClinicalTrials.gov/show/NCT00312598 |
Completed |
University of North Carolina, Chapel Hill |
2010-04-30 |
| NCT00294008 |
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) |
https://ClinicalTrials.gov/show/NCT00294008 |
Completed |
Janssen Korea, Ltd., Korea |
2009-06-30 |
| NCT00291200 |
Enhancing the Prospective Prediction of Psychosis |
https://ClinicalTrials.gov/show/NCT00291200 |
Completed |
Yale University |
2009-02-28 |
| NCT00283517 |
A Registry of Treatment Adherence for Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00283517 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT00269464 |
Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype? |
https://ClinicalTrials.gov/show/NCT00269464 |
Completed |
Sheba Medical Center |
NA |
| NCT00264069 |
ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry |
https://ClinicalTrials.gov/show/NCT00264069 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT00253240 |
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population |
https://ClinicalTrials.gov/show/NCT00253240 |
Completed |
Lawson Health Research Institute |
NA |
| NCT00247637 |
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00247637 |
Completed |
University of California, San Diego |
2008-09-30 |
| NCT00246194 |
Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) |
https://ClinicalTrials.gov/show/NCT00246194 |
Completed |
Janssen, LP |
2007-11-30 |
| NCT00224276 |
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics |
https://ClinicalTrials.gov/show/NCT00224276 |
Completed |
Yale University |
NA |
| NCT00222807 |
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT00222807 |
Completed |
University of Pittsburgh |
2016-03-31 |
| NCT00223522 |
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data? |
https://ClinicalTrials.gov/show/NCT00223522 |
Completed |
The University of Texas Health Science Center at San Antonio |
NA |
| NCT00216723 |
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder |
https://ClinicalTrials.gov/show/NCT00216723 |
Completed |
Korea Otsuka Pharmaceutical Co., Ltd. |
NA |
| NCT00184418 |
The Immune System and Psychiatric Disorders |
https://ClinicalTrials.gov/show/NCT00184418 |
Completed |
Norwegian University of Science and Technology |
2008-01-31 |
| NCT00172731 |
Measurement of Activity Participation for Persons With Schizophrenia Living in the Community |
https://ClinicalTrials.gov/show/NCT00172731 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00161057 |
Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment |
https://ClinicalTrials.gov/show/NCT00161057 |
Completed |
UMC Utrecht |
NA |
| NCT00155701 |
Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00155701 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00155688 |
A Genetic Linkage Study of Schizophrenia |
https://ClinicalTrials.gov/show/NCT00155688 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00155649 |
A Positional Cloning Study on Schizophrenia |
https://ClinicalTrials.gov/show/NCT00155649 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00155818 |
Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00155818 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00155519 |
A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions |
https://ClinicalTrials.gov/show/NCT00155519 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00155506 |
Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios |
https://ClinicalTrials.gov/show/NCT00155506 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00135772 |
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 |
https://ClinicalTrials.gov/show/NCT00135772 |
Completed |
National Institute on Drug Abuse (NIDA) |
2004-07-31 |
| NCT00108303 |
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes |
https://ClinicalTrials.gov/show/NCT00108303 |
Completed |
VA Office of Research and Development |
2008-12-31 |
| NCT00833456 |
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00833456 |
Completed |
AstraZeneca |
2010-11-30 |
| NCT00080548 |
Timing of Voluntary Movement in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00080548 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00012961 |
Improving Health Services for Veterans With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00012961 |
Completed |
VA Office of Research and Development |
NA |
| NCT00836251 |
Effects of Antipsychotic Medications on Energy Intake and Expenditure |
https://ClinicalTrials.gov/show/NCT00836251 |
Completed |
Washington University School of Medicine |
2008-06-30 |
| NCT00006418 |
Molecular Genetics of Schizophrenia |
https://ClinicalTrials.gov/show/NCT00006418 |
Completed |
NorthShore University HealthSystem |
NA |
| NCT00001771 |
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00001771 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001323 |
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00001323 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001544 |
Genetic Aspects of Neurologic and Psychiatric Disorders |
https://ClinicalTrials.gov/show/NCT00001544 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001320 |
Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients |
https://ClinicalTrials.gov/show/NCT00001320 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001192 |
Neuropsychological Evaluation of Psychiatric and Neurological Patients |
https://ClinicalTrials.gov/show/NCT00001192 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001258 |
Studies of Frontal Lobe Brain Functioning in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00001258 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001921 |
Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings |
https://ClinicalTrials.gov/show/NCT00001921 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001920 |
Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00001920 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |